Key result
Disproportionate tricuspid regurgitation was associated with increased 2-year mortality compared to proportionate TR (HR 1.48; 95% CI 1.06-2.06), but not on multivariate analysis (p=0.94).
Why the study?
The prognostic impact of tricuspid regurgitation in acute heart failure remains uncertain.
Does disproportionate tricuspid regurgitation predict all-cause 2-year mortality in patients with acute heart failure?
Cohort (n=418)
Does disproportionate tricuspid regurgitation predict all-cause 2-year mortality in patients with acute heart failure?
Answers are grounded in this paper and cite their sources.
Quantitative assessment of disproportionate tricuspid regurgitation in acute heart failure was not independently associated with 2-year mortality after multivariate adjustment.
Background: The prognostic impact of tricuspid regurgitation (TR) in acute heart failure (AHF) remains uncertain. Methods: We retrospectively assessed 418 consecutive AHF patients who underwent comprehensive echocardiographic assessment within 24 h of study recruitment. TR was quantitatively assessed with 3 guideline-directed measures: regurgitant volumes (RgVol), effective regurgitant orifice area (ERO) and vena contracta (VC) diameter. Disproportionate TR was assessed by the ratio of the VC diameter to the tricuspid annulus diameter (VC/TA) ≥ 0.24. Results: The prevalence of significant (i.e., >mild) TR differed when various standard assessment parameters were applied to quantification: RgVol 50.3% (173/344), ERO 75.6% (260/344) and VC diameter 94.6% (335/354). None were able to delineate those at excess risk of all-cause 2-year mortality using guideline-directed cut-offs of mild, moderate and severe TR. Using a cut-off of VC/TA ≥ 0.24, we identified that 36.9% (130/352) had “disproportionate” TR. Disproportionate TR was associated with an excess risk of mortality at 2 years compared to proportionate TR; HR 1.48 (95% CI 1.06−2.06 [p = 0.02]) which was not significant on multivariate assessment (p = 0.94). Conclusions: TR was not associated with outcome in AHF using guideline measures. A new assessment of “Disproportionate” TR carries a higher risk than proportionate TR but was not related to outcome based on multivariate analysis. Further research is needed to quantify TR more effectively to identify cut-offs for future guidelines and disproportionate TR may be an important part of Heart Failure 2.0.
No takes yet. Share an insight, caveat, or question.
Berrill et al. (2022) conducted a cohort in Acute heart failure (n=418). Disproportionate tricuspid regurgitation (VC/TA ≥ 0.24) vs. Proportionate tricuspid regurgitation was evaluated on All-cause 2-year mortality (HR 1.48, 95% CI 1.06-2.06, p=0.02 (0.94 multivariate)). Disproportionate tricuspid regurgitation was associated with increased 2-year mortality compared to proportionate TR (HR 1.48; 95% CI 1.06-2.06), but not on multivariate analysis (p=0.94).
Synapse has enriched 10 related papers. Consider them for comparative context: